344 related articles for article (PubMed ID: 20868415)
1. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of opportunistic infections in hospitalized HIV-infected patients in Phnom Penh, Cambodia.
Senya C; Mehta A; Harwell JI; Pugatch D; Flanigan T; Mayer KH
Int J STD AIDS; 2003 Jun; 14(6):411-6. PubMed ID: 12816670
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of AIDS-associated cryptomeningitis.
Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal meningitis in HIV infected: experience from a North Indian tertiary center.
Kumar S; Wanchu A; Chakrabarti A; Sharma A; Bambery P; Singh S
Neurol India; 2008; 56(4):444-9. PubMed ID: 19127040
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
[TBL] [Abstract][Full Text] [Related]
7. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
8. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
10. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
Wadhwa A; Kaur R; Bhalla P
Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
[TBL] [Abstract][Full Text] [Related]
13. [Cryptococcal meningitis in HIV-infected patients at Bobo-Dioulasso hospital (Burkina Faso)].
Millogo A; Ki-Zerbo GA; Andonaba JB; Lankoandé D; Sawadogo A; Yaméogo I; Sawadogo AB
Bull Soc Pathol Exot; 2004 May; 97(2):119-21. PubMed ID: 15255356
[TBL] [Abstract][Full Text] [Related]
14. Hearing loss after discontinuing secondary prophylaxis for cryptococcal meningitis: relapse or immune reconstitution?
Khanna N; Nüesch R; Buitrago-Tellez C; Battegay M; Hirsch HH
Infection; 2006 Jun; 34(3):163-8. PubMed ID: 16804661
[TBL] [Abstract][Full Text] [Related]
15. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
[TBL] [Abstract][Full Text] [Related]
16. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
17. Survival time of HIV-infected patients with cryptococcal meningitis.
Chottanapund S; Singhasivanon P; Kaewkungwal J; Chamroonswasdi K; Manosuthi W
J Med Assoc Thai; 2007 Oct; 90(10):2104-11. PubMed ID: 18041430
[TBL] [Abstract][Full Text] [Related]
18. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
[TBL] [Abstract][Full Text] [Related]
19. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
Pongsai P; Atamasirikul K; Sungkanuparph S
J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcosis in HIV-infected children.
Likasitwattanakul S; Poneprasert B; Sirisanthana V
Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):935-9. PubMed ID: 15916094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
